Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells

PLoS ONE(2020)10.1371/journal.pone.0238070Source: DataRank Database

Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.64)OA: goldTopics (56)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Pranav S. Renavikar ORCID,Michael P. Crawford,Scott Steward-Tharp ORCID,Ashley A. Brate,Eva Tsalikian ORCID

Live enrichment

PubMed:32853219 OpenAlex:https://openalex.org/W3080415091

Foundation for the National Institutes of Health

Grant: R01AI092106

National Institutes of Health

Grant: 7R01AI092106-03

CNS-Specific Regulatory CD8+ T Cells in Autoimmune Demyelination

FWCI

0.64

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0238070&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0238070&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0238070

journalhttps://doi.org/10.1371/journal.pone.0238070

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32853219

Fields of Study

Diabetes and associated disordersImmune Cell Function and InteractionPhagocytosis and Immune Regulation0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AdultAllelesAnimalsAntigens, DifferentiationDiabetes Mellitus, Type 1FemaleGene Expression RegulationGenotypeHumansMaleMiddle AgedMultiple SclerosisReceptors, ImmunologicRecurrenceT-LymphocytesAutoimmunityCase-Control StudiesPolymorphism, Single NucleotideMiceYoung Adult

Keywords

AutoimmunityImmunologyImmune systemMultiple sclerosisBiologyT cellEffectorAdultMaleGenotypeScienceT-LymphocytesPolymorphism, Single NucleotideMiceYoung AdultRecurrenceAnimalsHumansReceptors, ImmunologicAllelesQRMiddle AgedAntigens, DifferentiationDiabetes Mellitus, Type 1Gene Expression RegulationCase-Control StudiesMedicineFemaleResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being